Your browser doesn't support javascript.
loading
Toxicological evaluation of exosomes derived from human adipose tissue-derived mesenchymal stem/stromal cells.
Ha, Dae Hyun; Kim, Sun-Don; Lee, Joon; Kwon, Hyuck Hoon; Park, Gyeong-Hun; Yang, Steve Hoseong; Jung, Jae Yoon; Lee, Jun Ho; Park, Sang Rae; Youn, Jinkwon; Lee, Sang Hee; Kim, Ji Eun; Lim, Jihye; Lee, Hyun-Kul; Cho, Byong Seung; Yi, Yong Weon.
Afiliación
  • Ha DH; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Kim SD; Nonclinical Research Institute, ChemOn Inc., Yongin-si, Gyeonggi-do, 17162, Republic of Korea.
  • Lee J; School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kwon HH; Oaro Dermatology Clinic, Seoul, 01695, Republic of Korea.
  • Park GH; Department of Dermatology, Dongtan Sacred Heart Hospital, College of Medicine, Hallym University, Hwaseong-si, Gyeonggi-do, Republic of Korea.
  • Yang SH; Guam Dermatology Institute, Tamuning, GU 96913, USA.
  • Jung JY; Oaro Dermatology Clinic, Seoul, 01695, Republic of Korea.
  • Lee JH; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Park SR; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Youn J; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Lee SH; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Kim JE; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Lim J; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.
  • Lee HK; Nonclinical Research Institute, ChemOn Inc., Yongin-si, Gyeonggi-do, 17162, Republic of Korea.
  • Cho BS; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea. Electronic address: ceo@exocobio.com.
  • Yi YW; ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea. Electronic address: yongweon.yi@exocobio.com.
Regul Toxicol Pharmacol ; 115: 104686, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32450131
ABSTRACT
Several studies report that the therapeutic mechanism of action of mesenchymal stem/stromal cells (MSCs) is mainly mediated by paracrine factors that are released from MSCs such as exosomes. Exosomes are nano-sized extracellular vesicles that are transferred to target cells for cell-to-cell communication. Although MSC-derived exosomes (MSC-exosomes) are suggested as novel cell-free therapeutics for various human diseases, evaluation studies for the safety and toxicity of MSC-exosomes are limited. The purpose of our study was to evaluate the toxicological profile, including skin sensitization, photosensitization, eye and skin irritation, and acute oral toxicity using exosomes derived from human adipose tissue-derived MSCs (ASC-exosomes) in accordance with the OECD guidelines and the principles of Good Laboratory Practice. The ASC-exosomes were classified as a potential non-sensitizer in the skin sensitization test, UN GHS no category in the eye irritation test, and as a skin non-irritant in the skin irritation test, and did not induce any toxicity in the phototoxicity test or in acute oral toxicity testing. Our findings are the first to suggest that ASC-exosomes are safe for use as a topical treatment, with no adverse effects in toxicological testing, and have potential application as a therapeutic agent, cosmetic ingredient, or for other biological uses.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas Tipo de estudio: Guideline Límite: Animals / Female / Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas Tipo de estudio: Guideline Límite: Animals / Female / Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2020 Tipo del documento: Article